Relief Therapeutics Holding SA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CHF 6.03 million compared to CHF 6.08 million a year ago. Revenue was CHF 6.33 million compared to CHF 7.11 million a year ago.

Net loss was CHF 98.18 million compared to CHF 50.79 million a year ago. Basic loss per share from continuing operations was CHF 8.354 compared to CHF 4.805 a year ago.